CLAIM #33952 · Johnson & Johnson (JNJ) · 2024Q3 earnings call · Oct 15, 2024 · due Dec 31, 2024
“And then finally, across the portfolio, we're benefiting from tremendous new product launches... And typically, that fourth quarter also is a stronger one for us. So, once again, very confident in our performance at around 5% on an adjusted basis and north of 6% operationally.”
Timothy Schmid · Segment Leader
In context
“dynamic here is that, as we signaled in the first and second quarter, we expect to see improvement within our Vision business, which typically has delivered solid single -- mid-single-digit growth. We had a tremendous third quarter, which really gives us confidence in even stronger fourth. This was delivered by much better performance, especially in our contact lens business. In fact, here in the U.S., our most important market, double-digit growth for contact lenses in the quarter. And this just really has been delivered from a stabilization of our distributor inventory in the U.S., the fact that we're able to get back to taking new wearer share now that we have unconstrained supply, especially within our astig portfolio. And so, we do believe that Vision has a very strong quarter ahead. And then finally, across the portfolio, we're benefiting from tremendous new product launches, both within Cardiovascular, the E8 peripheral catheter within Shockwave, continued performance within Abiomed with our broad portfolio of pumps. And then, within our surgery business as well as orthopaedics, as I mentioned earlier, tremendous new products to add differentiation to the portfolio. And typically, that fourth quarter also is a stronger one for us. So, once again, very confident in our performance at around 5% on an adjusted basis and north of 6% operationally. Thank you. Jessica Moore: Thank you, Jayson, and thanks to everyone for your questions and your continued interest in our company. We apologize to those we couldn't get to because of time, but don't hesitate to reach out to the Investor Relations team with any remaining questions that you may have. I would now turn the call over to Joaquin for some brief closing remarks. Joaquin Duato: Thank you, everyone, for joining the call today. As you have heard, we delivered strong results in the third quarte”
Verify independently
SEC filings for JNJ ↗ · Claim quote is verbatim from the 2024Q3 earnings call.